{"entity":{"type":"insider","cik":"0001654058","url":"/insider/0001654058","json_url":"/insider/0001654058.json","name":"McCarthy Sean A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":38,"first":"2017-03-03","last":"2026-03-19","span_basis":"filed_date"},"name_variants":[{"name":"McCarthy Sean A.","source":"filing","n_filings":38,"first_seen":"2017-03-03","last_seen":"2026-03-19"}],"transactions":[{"id":5778055,"accession":"0001610717-26-000124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-26-000124","line_url":"/filing/0001610717-26-000124#line-1","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":118969.0,"shares_display":"118,969","price_per_share":6.423,"price_display":"6.42","price_state":"stated","total_value":764137.887,"total_display":"764,137.89","total_whole":"764,138","shares_owned_after":1078922.0,"shares_owned_after_display":"1,078,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-19","scope":"insider"},{"id":5141865,"accession":"0001610717-25-000372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000372","line_url":"/filing/0001610717-25-000372#line-1","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101793.0,"shares_display":"101,793","price_per_share":4.5377,"price_display":"4.54","price_state":"stated","total_value":461906.0961,"total_display":"461,906.10","total_whole":"461,906","shares_owned_after":987891.0,"shares_owned_after_display":"987,891","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-06","filed_date":"2025-11-10","scope":"insider"},{"id":4723714,"accession":"0001610717-25-000234","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-25-000234","line_url":"/filing/0001610717-25-000234#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55511.0,"shares_display":"55,511","price_per_share":2.6889,"price_display":"2.69","price_state":"stated","total_value":149263.5279,"total_display":"149,263.53","total_whole":"149,264","shares_owned_after":1089684.0,"shares_owned_after_display":"1,089,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-16","filed_date":"2025-06-17","scope":"insider"},{"id":4516177,"accession":"0001610717-25-000086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000086","line_url":"/filing/0001610717-25-000086#line-1","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37656.0,"shares_display":"37,656","price_per_share":0.599,"price_display":"0.60","price_state":"stated","total_value":22555.944,"total_display":"22,555.94","total_whole":"22,556","shares_owned_after":995195.0,"shares_owned_after_display":"995,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-18","filed_date":"2025-03-20","scope":"insider"},{"id":2567831,"accession":"0001610717-24-000432","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-24-000432","line_url":"/filing/0001610717-24-000432#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13898.0,"shares_display":"13,898","price_per_share":1.2291,"price_display":"1.23","price_state":"stated","total_value":17082.0318,"total_display":"17,082.03","total_whole":"17,082","shares_owned_after":657851.0,"shares_owned_after_display":"657,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-22","scope":"insider"},{"id":3186370,"accession":"0001610717-24-000178","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000178","line_url":"/filing/0001610717-24-000178#line-1","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20223.0,"shares_display":"20,223","price_per_share":2.0855,"price_display":"2.09","price_state":"stated","total_value":42175.0665,"total_display":"42,175.07","total_whole":"42,175","shares_owned_after":524481.0,"shares_owned_after_display":"524,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-21","scope":"insider"},{"id":8689810,"accession":"0001610717-23-000423","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-23-000423","line_url":"/filing/0001610717-23-000423#line-1","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13551.0,"shares_display":"13,551","price_per_share":1.3807,"price_display":"1.38","price_state":"stated","total_value":18709.8657,"total_display":"18,709.87","total_whole":"18,710","shares_owned_after":454704.0,"shares_owned_after_display":"454,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-20","filed_date":"2023-12-22","scope":"insider"},{"id":7935276,"accession":"0001610717-23-000297","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-23-000297","line_url":"/filing/0001610717-23-000297#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14601.0,"shares_display":"14,601","price_per_share":1.3004,"price_display":"1.30","price_state":"stated","total_value":18987.1404,"total_display":"18,987.14","total_whole":"18,987","shares_owned_after":430755.0,"shares_owned_after_display":"430,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-22","filed_date":"2023-09-22","scope":"insider"},{"id":8017572,"accession":"0001140361-23-012618","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-012618","line_url":"/filing/0001140361-23-012618#line-1","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7121.0,"shares_display":"7,121","price_per_share":1.8805,"price_display":"1.88","price_state":"stated","total_value":13391.0405,"total_display":"13,391.04","total_whole":"13,391","shares_owned_after":388821.0,"shares_owned_after_display":"388,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-20","scope":"insider"},{"id":6906203,"accession":"0001567619-22-014299","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-014299","line_url":"/filing/0001567619-22-014299#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14911.0,"shares_display":"14,911","price_per_share":1.4222,"price_display":"1.42","price_state":"stated","total_value":21206.4242,"total_display":"21,206.42","total_whole":"21,206","shares_owned_after":290942.0,"shares_owned_after_display":"290,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-20","filed_date":"2022-07-21","scope":"insider"},{"id":4482169,"accession":"0001567619-21-012419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-012419","line_url":"/filing/0001567619-21-012419#line-1","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":7.0447,"price_display":"7.04","price_state":"stated","total_value":704470.0,"total_display":"704,470.00","total_whole":"704,470","shares_owned_after":93118.0,"shares_owned_after_display":"93,118","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-16","filed_date":"2021-06-21","scope":"insider"},{"id":5464219,"accession":"0001567619-21-007541","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-007541","line_url":"/filing/0001567619-21-007541#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":7.4947,"price_display":"7.49","price_state":"stated","total_value":749470.0,"total_display":"749,470.00","total_whole":"749,470","shares_owned_after":206894.0,"shares_owned_after_display":"206,894","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-31","filed_date":"2021-04-02","scope":"insider"},{"id":2825538,"accession":"0001567619-20-010115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-010115","line_url":"/filing/0001567619-20-010115#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":540000.0,"total_display":"540,000.00","total_whole":"540,000","shares_owned_after":84306.0,"shares_owned_after_display":"84,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-14","scope":"insider"},{"id":6315402,"accession":"0001567619-18-005081","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001567619-18-005081","line_url":"/filing/0001567619-18-005081#line-5","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1156.0,"shares_display":"1,156","price_per_share":15.007,"price_display":"15.01","price_state":"stated","total_value":17348.092,"total_display":"17,348.09","total_whole":"17,348","shares_owned_after":82063.0,"shares_owned_after_display":"82,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-02","filed_date":"2018-11-05","scope":"insider"},{"id":6315397,"accession":"0001567619-18-005081","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-18-005081","line_url":"/filing/0001567619-18-005081","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5370.0,"shares_display":"5,370","price_per_share":15.000093109869646,"price_display":"15.00","price_state":"stated","total_value":80550.5,"total_display":"80,550.50","total_whole":"80,551","shares_owned_after":82063.0,"shares_owned_after_display":"82,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-01","filed_date":"2018-11-05","scope":"insider","n_lines":2},{"id":6708679,"accession":"0001567619-18-002231","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-18-002231","line_url":"/filing/0001567619-18-002231#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13052.0,"shares_display":"13,052","price_per_share":21.862,"price_display":"21.86","price_state":"stated","total_value":285342.824,"total_display":"285,342.82","total_whole":"285,343","shares_owned_after":82063.0,"shares_owned_after_display":"82,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-06","scope":"insider"},{"id":6749227,"accession":"0001140361-18-031945","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-031945","line_url":"/filing/0001140361-18-031945#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4497.0,"shares_display":"4,497","price_per_share":25.0586,"price_display":"25.06","price_state":"stated","total_value":112688.5242,"total_display":"112,688.52","total_whole":"112,689","shares_owned_after":82063.0,"shares_owned_after_display":"82,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-05","filed_date":"2018-07-09","scope":"insider"},{"id":5984552,"accession":"0001140361-18-031810","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-031810","line_url":"/filing/0001140361-18-031810#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2028.0,"shares_display":"2,028","price_per_share":25.089,"price_display":"25.09","price_state":"stated","total_value":50880.492,"total_display":"50,880.49","total_whole":"50,880","shares_owned_after":82063.0,"shares_owned_after_display":"82,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-03","filed_date":"2018-07-06","scope":"insider"},{"id":6445102,"accession":"0001140361-18-031327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-031327","line_url":"/filing/0001140361-18-031327#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13052.0,"shares_display":"13,052","price_per_share":23.4223,"price_display":"23.42","price_state":"stated","total_value":305707.8596,"total_display":"305,707.86","total_whole":"305,708","shares_owned_after":82063.0,"shares_owned_after_display":"82,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-03","scope":"insider"},{"id":6266647,"accession":"0001140361-18-021344","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-021344","line_url":"/filing/0001140361-18-021344#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19578.0,"shares_display":"19,578","price_per_share":26.5473,"price_display":"26.55","price_state":"stated","total_value":519743.0394,"total_display":"519,743.04","total_whole":"519,743","shares_owned_after":4643.0,"shares_owned_after_display":"4,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-01","filed_date":"2018-05-02","scope":"insider"},{"id":6097760,"accession":"0001140361-18-012008","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-18-012008","line_url":"/filing/0001140361-18-012008#line-4","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19578.0,"shares_display":"19,578","price_per_share":29.428,"price_display":"29.43","price_state":"stated","total_value":576141.384,"total_display":"576,141.38","total_whole":"576,141","shares_owned_after":4643.0,"shares_owned_after_display":"4,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-05","scope":"insider"},{"id":6487631,"accession":"0001140361-18-001360","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-001360","line_url":"/filing/0001140361-18-001360#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6526.0,"shares_display":"6,526","price_per_share":25.01,"price_display":"25.01","price_state":"stated","total_value":163215.26,"total_display":"163,215.26","total_whole":"163,215","shares_owned_after":4643.0,"shares_owned_after_display":"4,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-05","filed_date":"2018-01-09","scope":"insider"},{"id":6025081,"accession":"0001140361-18-000712","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-000712","line_url":"/filing/0001140361-18-000712#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13052.0,"shares_display":"13,052","price_per_share":21.04,"price_display":"21.04","price_state":"stated","total_value":274614.08,"total_display":"274,614.08","total_whole":"274,614","shares_owned_after":4643.0,"shares_owned_after_display":"4,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":4126810,"accession":"0001140361-17-045017","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-045017","line_url":"/filing/0001140361-17-045017#line-4","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14340.0,"shares_display":"14,340","price_per_share":20.6,"price_display":"20.60","price_state":"stated","total_value":295404.0,"total_display":"295,404.00","total_whole":"295,404","shares_owned_after":4643.0,"shares_owned_after_display":"4,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider"},{"id":5224107,"accession":"0001140361-17-040976","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-040976","line_url":"/filing/0001140361-17-040976#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14342.0,"shares_display":"14,342","price_per_share":19.86,"price_display":"19.86","price_state":"stated","total_value":284832.12,"total_display":"284,832.12","total_whole":"284,832","shares_owned_after":4245.0,"shares_owned_after_display":"4,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-01","filed_date":"2017-11-03","scope":"insider"},{"id":4818715,"accession":"0001140361-17-037828","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-037828","line_url":"/filing/0001140361-17-037828#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19120.0,"shares_display":"19,120","price_per_share":24.13,"price_display":"24.13","price_state":"stated","total_value":461365.6,"total_display":"461,365.60","total_whole":"461,366","shares_owned_after":4245.0,"shares_owned_after_display":"4,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-04","filed_date":"2017-10-06","scope":"insider"},{"id":4864193,"accession":"0001140361-17-037691","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-037691","line_url":"/filing/0001140361-17-037691#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9562.0,"shares_display":"9,562","price_per_share":18.57,"price_display":"18.57","price_state":"stated","total_value":177566.34,"total_display":"177,566.34","total_whole":"177,566","shares_owned_after":4245.0,"shares_owned_after_display":"4,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":9233431,"accession":"0001140361-17-036202","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-036202","line_url":"/filing/0001140361-17-036202","is_derivative":false,"issuer_cik":"0001654058","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001654058","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9930.0,"shares_display":"9,930","price_per_share":17.32667069486405,"price_display":"17.33","price_state":"stated","total_value":172053.84,"total_display":"172,053.84","total_whole":"172,054","shares_owned_after":4613.0,"shares_owned_after_display":"4,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-01","filed_date":"2017-09-22","scope":"insider","n_lines":2},{"id":4172981,"accession":"0001140361-17-034348","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-034348","line_url":"/filing/0001140361-17-034348#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9930.0,"shares_display":"9,930","price_per_share":17.32,"price_display":"17.32","price_state":"stated","total_value":171987.6,"total_display":"171,987.60","total_whole":"171,988","shares_owned_after":4245.0,"shares_owned_after_display":"4,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-01","filed_date":"2017-09-05","scope":"insider"},{"id":9233429,"accession":"0001140361-17-036201","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-036201","line_url":"/filing/0001140361-17-036201","is_derivative":false,"issuer_cik":"0001654058","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001654058","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18756.0,"shares_display":"18,756","price_per_share":17.501599488163787,"price_display":"17.50","price_state":"stated","total_value":328260.0,"total_display":"328,260.00","total_whole":"328,260","shares_owned_after":16439.0,"shares_owned_after_display":"16,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-31","filed_date":"2017-09-22","scope":"insider","n_lines":3},{"id":4412808,"accession":"0001140361-17-034164","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-034164","line_url":"/filing/0001140361-17-034164","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18756.0,"shares_display":"18,756","price_per_share":17.501599488163787,"price_display":"17.50","price_state":"stated","total_value":328260.0,"total_display":"328,260.00","total_whole":"328,260","shares_owned_after":7245.0,"shares_owned_after_display":"7,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-31","filed_date":"2017-09-01","scope":"insider","n_lines":2},{"id":4172819,"accession":"0001140361-17-031315","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-031315","line_url":"/filing/0001140361-17-031315#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4781.0,"shares_display":"4,781","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":71715.0,"total_display":"71,715.00","total_whole":"71,715","shares_owned_after":4245.0,"shares_owned_after_display":"4,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-09","filed_date":"2017-08-11","scope":"insider"},{"id":5179532,"accession":"0001140361-17-027296","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-027296","line_url":"/filing/0001140361-17-027296#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4781.0,"shares_display":"4,781","price_per_share":15.52,"price_display":"15.52","price_state":"stated","total_value":74201.12,"total_display":"74,201.12","total_whole":"74,201","shares_owned_after":4245.0,"shares_owned_after_display":"4,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-03","filed_date":"2017-07-06","scope":"insider"},{"id":4702125,"accession":"0001140361-17-026273","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-026273","line_url":"/filing/0001140361-17-026273#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4481.0,"shares_display":"4,481","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":67215.0,"total_display":"67,215.00","total_whole":"67,215","shares_owned_after":4245.0,"shares_owned_after_display":"4,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-26","filed_date":"2017-06-27","scope":"insider"},{"id":5140952,"accession":"0001140361-17-024051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-024051","line_url":"/filing/0001140361-17-024051#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":4500.0,"total_display":"4,500.00","total_whole":"4,500","shares_owned_after":4245.0,"shares_owned_after_display":"4,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-05","filed_date":"2017-06-06","scope":"insider"},{"id":4235987,"accession":"0001140361-17-017962","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-017962","line_url":"/filing/0001140361-17-017962#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4781.0,"shares_display":"4,781","price_per_share":15.7,"price_display":"15.70","price_state":"stated","total_value":75061.7,"total_display":"75,061.70","total_whole":"75,062","shares_owned_after":1979.0,"shares_owned_after_display":"1,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-02","scope":"insider"},{"id":4189207,"accession":"0001140361-17-014775","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-014775","line_url":"/filing/0001140361-17-014775#line-4","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4781.0,"shares_display":"4,781","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":83667.5,"total_display":"83,667.50","total_whole":"83,668","shares_owned_after":1979.0,"shares_owned_after_display":"1,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-04","filed_date":"2017-04-05","scope":"insider"},{"id":4189203,"accession":"0001140361-17-014775","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-014775","line_url":"/filing/0001140361-17-014775#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4781.0,"shares_display":"4,781","price_per_share":16.94,"price_display":"16.94","price_state":"stated","total_value":80990.14,"total_display":"80,990.14","total_whole":"80,990","shares_owned_after":1979.0,"shares_owned_after_display":"1,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-03","filed_date":"2017-04-05","scope":"insider"},{"id":4172072,"accession":"0001140361-17-012869","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-012869","line_url":"/filing/0001140361-17-012869#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14343.0,"shares_display":"14,343","price_per_share":19.6,"price_display":"19.60","price_state":"stated","total_value":281122.8,"total_display":"281,122.80","total_whole":"281,123","shares_owned_after":1979.0,"shares_owned_after_display":"1,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-20","filed_date":"2017-03-21","scope":"insider"},{"id":4862835,"accession":"0001140361-17-010608","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-010608","line_url":"/filing/0001140361-17-010608#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001654058","owner_name":"McCarthy Sean A.","owner_display_name":"McCarthy Sean A.","owner_url":"/insider/0001654058","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14343.0,"shares_display":"14,343","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":215145.0,"total_display":"215,145.00","total_whole":"215,145","shares_owned_after":1979.0,"shares_owned_after_display":"1,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-03","filed_date":"2017-03-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":45,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":45,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":45},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001501989","name":"CytomX Therapeutics, Inc.","url":"/issuer/0001501989","role":"Director, Officer (CEO)","n_filings":38,"first_seen":"2017-03-03","last_seen":"2026-03-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001654058","retrieved_at":"2026-08-27T20:42:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}